National Institutes of Health

New therapies show promise in treating diabetes
New therapies show promise in treating diabetesNew updates in insulin products, as well as non-pharma therapies are on the horizon for diabetes.
Four things executives need to know to combat rising drug spendExecutives need to ask themselves four key questions to mitigate the negative impact of rising drug costs.
Getting ready for ARVO 2017: New president, special OCT issueLearn about the latest updates from The Association for Research in Vision and Ophthalmology for 2017 and beyond.
How social factors are driving precision medicinePrecision medicine isn’t just about genomics anymore. With the field moving forward as the next step in population health management, environmental, social and lifestyle factors that live outside the medical system are increasingly important to target treatments and engage patients. That means health plans also need innovative technology solutions to capture, store and integrate this crucial information.
Hearing ups pressure on drugmakers’ pricesWhen the House Committee on Oversight and Government Reform met on January 26, legislators took a closer look at price hikes from companies such as Valeant Pharmaceuticals and Turing Pharmaceuticals.
SPRINT study: Aim for lower blood pressure target to save livesEarly data from a clinical study supported by the National Institutes of Health found that adults with hypertension and at least one other risk factor for heart disease were less likely to have a heart attack, stroke, or heart failure with a reduction of systolic blood pressure to 120 mm Hg.
The 21st Century Cures Act: five things to knowHere are five of key things managed healthcare executives should know about the act.
NIH to reboot environmental studyAfter the implosion late last year of the 14-year effort for a comprehensive national study of the environmental effects on children, Congress has told the National Institutes of Health (NIH) to try again.
Exploring Precision Medicine's value
Exploring Precision Medicine's valueConsensus is building on the promise of genetic testing and other technological advances to help individualize testing, prevention and treatment for better outcomes.
How much do women understand about breast density? And other current researchA research round-up on how much women understand about breast density and the role of lycopene in kidney cancer risk. Plus, NICHD pledges money for research into the placenta.